How many clinical trials are tracked of Zometa?

4 trials are tracked, 0 with published results.

Mode

All Oncology Infectious Disease Neurology Psychiatry Cardiology Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Primary Care & Family Medicine Gastroenterology Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Genetics & Precision Medicine Anesthesiology & Pain Medicine Pulmonology & Critical Care Physical Medicine & Rehab Nephrology Emergency Medicine Urology Ophthalmology Hematology Dermatology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Zometa

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of Zometa

4 trials tracked of Zometa: 1 in phase 3 or 4.

4Trials tracked

1Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 3 1 Phase 2 3

Phase 3 Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) Completed
Phase 2 Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) Completed
Phase 2 Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy Completed
Phase 2 Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.